CapVest Acquires Majority Stake in STADA Arzneimittel

Astorg Acquires Majority Stake in Steliau

February 26, 2024

Industrial Services

Astorg, a European private equity firm, has signed an agreement to acquire a majority stake in Steliau, a pan-European value-added distributor (VAD) of electronic solutions, from B&Capital. Steliau, founded in 1992 and headquartered in Montrouge, France, employs more than 200 people across eight countries and will partner with Astorg to accelerate organic growth and execute a buy-and-build strategy.

CapVest Acquires Natra from Investindustrial

July 18, 2022

Food & Beverage

Funds managed by CapVest Partners LLP have signed an agreement to acquire Natra, a European producer and distributor of chocolate and cocoa products, from Investindustrial. The deal gives CapVest a platform in the chocolate category to accelerate international growth, support innovation and pursue strategic acquisitions.

STADA Acquires Biopharma's Pharmaceutical Prescription and Consumer Health Business

December 12, 2019

Pharmaceuticals

The STADA Group agreed to acquire the pharmaceutical prescription and consumer health business of Ukrainian producer Biopharma, including GMP-certified production facilities in Bila Tserkva. The deal integrates Biopharma's pharma operations into STADA's European organization, expands STADA's local production footprint in Ukraine and is subject to Ukrainian merger control; Biopharma's shareholders will retain the company's plasma business.

STADA Acquires Walmark from MidEuropa

November 4, 2019

Consumer Products

STADA Arzneimittel AG has agreed to acquire Walmark a.s., a leading consumer healthcare company in Central Europe, from private equity firm MidEuropa Partners. The deal (consideration undisclosed) expands STADA's branded consumer health portfolio and strengthens its presence across Central and Eastern Europe; the transaction was expected to close in Q1 2020 subject to antitrust clearance.

Equistone Partners Europe Acquires Majority Stake in Omnicare

August 14, 2019

Pharmaceuticals

Equistone Partners Europe has agreed to acquire a majority stake in Omnicare, a German pharmaceutical wholesaler specializing in distribution of finished medicines to compounding pharmacies for patient-specific oncology treatments. The seller is a consortium of shareholders that will retain a stake; Omnicare’s management, led by Oliver Tamimi, will remain in place and the deal (terms undisclosed) is expected to close in Q4 2019.

GHO Capital Acquires Majority Stake in Sterling Pharma Solutions

February 28, 2019

Pharmaceuticals

GHO Capital has acquired a majority stake in Sterling Pharma Solutions alongside management. The investment will support Sterling's international expansion and accelerate growth of its specialist API development and GMP manufacturing capabilities from its UK base in Newcastle upon Tyne.